Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Nov 17;16:5367–5383. doi: 10.2147/JIR.S431628

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 Liu et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Diagnostic values of METTL1-coexpressed ImmuneDEGs in both discovery and validated cohorts. (A) ROC analysis for METTL1 in GSE122459; (B) ROC analysis for LAMP3, CD83, and PDCD1LG2 in GSE122459; (C) ROC analysis for IGKV5-2, IGKV3D-20, IGLV4-60, IGLV3-19, and IGKV2D-30 in GSE122459; (D) ROC analysis for METTL1 in our SLE cohort; (E) ROC analysis for LAMP3, CD83, and PDCD1LG2 in GSE50772.

Abbreviations: METTL1, Methyltransferase like 1; ImmuneDEGs, Immune-related differentially expressed genes; LAMP3, Lysosomal associated membrane protein 3; CD83, CD83 molecule; PDCD1LG2, Programmed cell death 1 ligand 2; ROC, Receiver operating characteristic curve.